Response to: Infliximab three-dose induction regimen in severe corticosteroid-refractory ulcerative colitis: Early and late outcome and predictors of colectomy

Research output: Contribution to journalLetterpeer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'Response to: Infliximab three-dose induction regimen in severe corticosteroid-refractory ulcerative colitis: Early and late outcome and predictors of colectomy'. Together they form a unique fingerprint.